Remdesivir works to stop replication of SARS-CoV-2, the virus that causes COVID-19, according to the drug's manufacturer, Gilead. Previously authorized by the FDA for emergency use to treat COVID-19, the drug is now the first approved COVID-19 treatment in the United States, Gilead said in a release. | |
News Alert Thursday, October 22 |
|
| | | | |
|